creatinol phosphate has been researched along with creatine in 21 studies
*Creatine: An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine. [MeSH]
*Creatine: An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (90.48) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Cadel, A; Conversano, S; Fanciulli, R; Galbiati, R; Palumbo, A; Pria, R; Zerilli, G | 1 |
| Ghirardi, P; Marzo, A | 3 |
| Barlattani, M; Guglielmi, G; Mammarella, A | 1 |
| Di Maio, F; Neri, A; Sciacca, A; Soccorsi, P | 1 |
| Guglielmi, G; Mammarella, A | 1 |
| Godfraind, T | 1 |
| Casagrande, C; Ferrari, G | 1 |
| Brusoni, B; Lureti, GF; Melloni, GF; Merlo, L; Minoja, GM; Pamparana, F | 1 |
| Godfraind, T; Sturbois, X | 1 |
| Ghysel-Burton, J; Godfraind, T; Merlo, L | 1 |
| Ghysel-Burton, J; Godfraind, T; Sturbois, X | 1 |
| Ferrini, R; Miragoli, G | 2 |
| Bana, G; Knippel, M; Pusterla, GL | 1 |
| Bonatti, V; Botti, G | 1 |
| Belardinelli, L; Berne, RM | 1 |
| Godfraind, T; Saleh, MM | 1 |
| Bernardi, M; Moretti, V; Olsen, JI; Re, L; Rossini, L; Rossini, P; Schweizer, MP | 1 |
| Casarini, DE; Gloria, MA; Leite, APO; Luiz, RS; Muller, CR; Razvickas, CV; Reinecke, N; Saud, A; Schor, N; Silva, WH; Visona, I | 1 |
1 review(s) available for creatinol phosphate and creatine
| Article | Year |
|---|---|
Pharmacological and toxicological properties of creatinol O-phosphate. A review.
Topics: Animals; Creatine; Female; Fertility; Guinea Pigs; Kinetics; Mice; Pregnancy; Rabbits; Rats; Teratogens | 1979 |
6 trial(s) available for creatinol phosphate and creatine
| Article | Year |
|---|---|
Antiarrhythmic effectiveness of creatinol O-phosphate in man.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Creatine; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Time Factors | 1979 |
Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Creatine; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged | 1979 |
Activity of creatinol O-phosphate on persistent ventricular premature beats in ischemic heart disease. Double blind clinical trial.
Topics: Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Creatine; Double-Blind Method; Female; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1979 |
[Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Creatine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Placebos | 1979 |
Acute clinical tolerance of creatinol O-phosphate.
Topics: Adolescent; Adult; Aged; Creatine; Diuresis; Drug Tolerance; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Time Factors | 1979 |
Effects of creatinol O-phosphate on serum enzymes in acute myocardial infarction.
Topics: Acute Disease; Creatine; Depression, Chemical; Enzymes; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 1979 |
14 other study(ies) available for creatinol phosphate and creatine
| Article | Year |
|---|---|
Concepts leading to the development of an anti-ischemic drug. Introductory remarks.
Topics: Coronary Disease; Creatine; Hemodynamics; Humans; Myocardial Contraction; Necrosis | 1979 |
Synthesis and chemical properties of N- and O-phosphorylated derivatives of creatinol.
Topics: Chemical Phenomena; Chemistry; Creatine; Hydrolysis; Time Factors | 1979 |
Pharmacokinetics of creatinol O-phosphate. Plasma turnover, fate and excretion rate, subcellular distribution in isolated perfused heart and metabolic behaviour.
Topics: Animals; Biotransformation; Creatine; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Myocardium; Rats; Subcellular Fractions; Time Factors; Tissue Distribution | 1979 |
An analysis of the reduction by creatinol O-phosphate of the myocardial lesions evoked by isoprenaline in the rat.
Topics: Animals; Cardiomyopathies; Coronary Circulation; Creatine; Isoproterenol; Male; Microcirculation; Myocardium; Necrosis; Rats | 1979 |
The action of creatinol 0-phosphate on the inotropic effect of isoprenaline in isolated rat atria and in anesthetized dogs.
Topics: Animals; Creatine; Dogs; Drug Interactions; Female; Hemodynamics; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Rats; Time Factors | 1979 |
Ionic changes evoked by isoprenaline in rat hearts in vivo and in vitro and their reduction by creatinol O-phosphate.
Topics: Animals; Calcium; Creatine; Female; Heart; In Vitro Techniques; Isoproterenol; Magnesium; Myocardial Contraction; Myocardium; Rats; Time Factors | 1979 |
Protective action of creatinol O-phosphate against serum CPK activity enhanced by isoprenaline in the rat.
Topics: Animals; Creatine; Creatine Kinase; Female; Isoproterenol; Kinetics; Rats | 1979 |
Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice.
Topics: Animals; Calcium Chloride; Cinnarizine; Creatine; Electrocardiography; Female; Male; Mice; Prenylamine; Ventricular Fibrillation | 1979 |
Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chloroform; Creatine; Guinea Pigs; Humans; In Vitro Techniques; Male; Prenylamine; Quinidine; Ventricular Fibrillation | 1979 |
Preliminary report on electrophysiological effectiveness of creatinol O-phosphate (COP) in human subjects.
Topics: Aged; Arrhythmias, Cardiac; Atrioventricular Node; Bundle of His; Creatine; Electrocardiography; Electrophysiology; Female; Heart Conduction System; Humans; Male; Middle Aged; Purkinje Fibers | 1979 |
Effects of hypoxia and ischaemia on coronary vascular resistance, A-V node conduction and S-A node excitation.
Topics: Adenine Nucleotides; Adenosine; Aminophylline; Atrioventricular Node; Coronary Circulation; Coronary Vessels; Creatine; Cyclic AMP; Dipyridamole; Electrocardiography; Heart Conduction System; Humans; Hypoxia; Ischemia; Potassium; Sinoatrial Node; Vascular Resistance | 1985 |
Action of creatinol-O-phosphate on the contractility changes evoked by hypoxia and ischemia in rat isolated heart.
Topics: Animals; Creatine; Female; Glucose; Heart; In Vitro Techniques; Myocardial Contraction; Oxygen; Perfusion; Rats; Rats, Inbred Strains; Time Factors | 1984 |
A 31P NMR spectroscopy study of Xenopus laevis heart perfused in vitro with creatinol-O-phosphate, phosphocreatine, adenosine triphosphate, fructose diphosphate and ouabain.
Topics: Adenosine Triphosphate; Animals; Creatine; Fructosediphosphates; Heart; Magnetic Resonance Spectroscopy; Ouabain; Perfusion; Phosphocreatine; Phosphorus Radioisotopes; Rana temporaria; Rats; Xenopus laevis | 1993 |
Resistance exercise training ameliorates chronic kidney disease outcomes in a 5/6 nephrectomy model.
Topics: Animals; Creatine; Disease Models, Animal; Male; Nephrectomy; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Resistance Training | 2021 |